Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas

[1]  L. Callol,et al.  Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations. , 2007, Lung cancer.

[2]  P. Španěl,et al.  The challenge of breath analysis for clinical diagnosis and therapeutic monitoring. , 2007, The Analyst.

[3]  D. Fuchs,et al.  Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients , 2006, Dermatology.

[4]  D. Fuchs,et al.  Antitumoral activity of interferon-γ involved in impaired immune function in cancer patients , 2006 .

[5]  David Smith,et al.  A longitudinal study of methanol in the exhaled breath of 30 healthy volunteers using selected ion flow tube mass spectrometry, SIFT-MS , 2006, Physiological measurement.

[6]  David Smith,et al.  Combined use of gas chromatography and selected ion flow tube mass spectrometry for absolute trace gas quantification. , 2006, Rapid communications in mass spectrometry : RCM.

[7]  Stefan Schneeberger,et al.  Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  N. Waugh,et al.  The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. , 2006, Health technology assessment.

[9]  David Smith,et al.  Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. , 2005, Mass spectrometry reviews.

[10]  W. Wade,et al.  Isolation and molecular detection of methylotrophic bacteria occurring in the human mouth. , 2005, Environmental microbiology.

[11]  L. Bianchi,et al.  Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.

[12]  P. Mazzone,et al.  Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.

[13]  Anthony J Alberg,et al.  Epidemiology of lung cancer: looking to the future. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Ferlay,et al.  Cancer incidence and mortality in Europe, 2004. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  S. Telser,et al.  Applications of breath gas analysis in medicine , 2004 .

[16]  W. Miekisch,et al.  Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[17]  Terence H Risby,et al.  Effects of ventilation on the collection of exhaled breath in humans. , 2004, Journal of applied physiology.

[18]  A. Basler,et al.  Formaldehyde-induced sister chromatid exchanges in vitro and the influence of the exogenous metabolizing systems S9 mix and primary rat hepatocytes , 1985, Archives of Toxicology.

[19]  A. Báez,et al.  Measurements of carbonyls in a 13-story building , 2004, Environmental science and pollution research international.

[20]  Terence H Risby,et al.  Human exposure to the jet fuel, JP-8. , 2004, Aviation, space, and environmental medicine.

[21]  W. Schobersberger,et al.  Sevoflurane in Exhaled Air of Operating Room Personnel , 2003, Anesthesia and analgesia.

[22]  Kevin Gleeson,et al.  Detection of lung cancer with volatile markers in the breath. , 2003, Chest.

[23]  M. Phillips,et al.  Volatile Markers of Breast Cancer in the Breath , 2003, The breast journal.

[24]  David Smith,et al.  Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.

[25]  J. Cape.  Effects of airborne volatile organic compounds on plants. , 2003, Environmental pollution.

[26]  Peter B Bach,et al.  Screening for lung cancer: the guidelines. , 2003, Chest.

[27]  Douglas C McCrory,et al.  Screening for lung cancer: a review of the current literature. , 2003, Chest.

[28]  R. Fall,et al.  Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. , 2001, Journal of applied physiology.

[29]  M. Lidstrom,et al.  Novel Formaldehyde-Activating Enzyme inMethylobacterium extorquens AM1 Required for Growth on Methanol , 2000, Journal of bacteriology.

[30]  P. Spanĕl,et al.  Influence of water vapour on selected ion flow tube mass spectrometric analyses of trace gases in humid air and breath. , 2000, Rapid communications in mass spectrometry : RCM.

[31]  M. Phillips,et al.  Effect of age on the profile of alkanes in normal human breath , 2000, Free radical research.

[32]  H. Bartsch,et al.  Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  T. Holland,et al.  Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. , 1999, Rapid communications in mass spectrometry : RCM.

[34]  M. Phillips,et al.  Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[35]  R. Cataneo,et al.  Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.

[36]  S. Paulson,et al.  Human breath emissions of VOCs. , 1999, Journal of the Air & Waste Management Association.

[37]  A. Hansel,et al.  On-line monitoring of volatile organic compounds at pptv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS) medical applications, food control and environmental research , 1998 .

[38]  M. Phillips.  Method for the collection and assay of volatile organic compounds in breath. , 1997, Analytical biochemistry.

[39]  Werner Lindinger,et al.  Proton transfer reaction mass spectrometry: on-line trace gas analysis at the ppb level , 1995 .

[40]  M. Phillips,et al.  Metabolic and environmental origins of volatile organic compounds in breath. , 1994, Journal of clinical pathology.

[41]  G Smith,et al.  A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. , 1994, Biochemical pharmacology.

[42]  J. Mclaughlin.  Formaldehyde and cancer: a critical review , 1994, International archives of occupational and environmental health.

[43]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[44]  E. Ziegel,et al.  Bootstrapping: A Nonparametric Approach to Statistical Inference , 1993 .

[45]  N. Danford.  The genetic toxicology of ortho-toluidine. , 1991, Mutation research.

[46]  Identification of exposure markers in smokers' breath. , 1990, Journal of chromatography.

[47]  A. Van Gossum,et al.  Increased lipid peroxidation after lipid infusion as measured by breath pentane output. , 1988, The American journal of clinical nutrition.

[48]  A. Van Gossum,et al.  Plasma vitamin E and selenium and breath pentane in home parenteral nutrition patients. , 1988, The American journal of clinical nutrition.

[49]  G. Preti,et al.  Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. , 1988, Journal of chromatography.

[50]  David G. Stork,et al.  Pattern Classification , 1973 .

[51]  A. B. Robinson,et al.  Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J F NUNN.  Elimination of carbon dioxide by the lung. , 1960, Anesthesiology.